Lv3
348 积分 2023-12-24 加入
A renaissance in targeting the PI3K/AKT/mTOR pathway
4天前
已完结
The present and future of PI3K inhibitors for cancer therapy
4天前
已完结
Degrader-antibody conjugates
9天前
已完结
What influences the activity of Degrader−Antibody conjugates (DACs)
9天前
已完结
Structural and Functional Determinants of ARIA-H Risk in Anti-Amyloid Monoclonal Antibodies: A Comparative Mechanistic Framework for Alzheimer's Immunotherapy Development
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
4个月前
已完结
LBA49 Efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC) and actionable genomic alterations (AGAs): Preliminary results from the phase I TROPION-PanTumor01 study
4个月前
已完结
Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
5个月前
已完结
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
5个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
7个月前
已完结
皖公网安备34019202002308
